A Cost-Effective Rabbit Embolic Stroke Bioassay: Insight into the Development of Acute Ischemic Stroke Therapy

被引:16
作者
Lapchak, Paul A. [1 ,2 ]
机构
[1] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA
关键词
TISSUE-PLASMINOGEN-ACTIVATOR; CLINICAL RATING SCORES; CEREBRAL-ISCHEMIA; HEMORRHAGIC TRANSFORMATION; INTRACEREBRAL HEMORRHAGE; NEUROTHERA EFFECTIVENESS; THROMBOLYTIC THERAPY; PRECLINICAL RESEARCH; POOLED ANALYSIS; LASER THERAPY;
D O I
10.1007/s12975-015-0386-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:99 / 103
页数:5
相关论文
共 74 条
[1]   Intravenous tissue-type plasminogen activator for treatment of acute stroke - The standard treatment with alteplase to reverse stroke (STARS) study [J].
Albers, GW ;
Bates, VE ;
Clark, WM ;
Bell, R ;
Verro, P ;
Hamilton, SA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1145-1150
[2]   Steps to Translate Preconditioning from Basic Research to the Clinic [J].
Bahjat, Frances R. ;
Gesuete, Raffaella ;
Stenzel-Poore, Mary P. .
TRANSLATIONAL STROKE RESEARCH, 2013, 4 (01) :89-103
[3]   Cost-Effectiveness of Recombinant Tissue-Type Plasminogen Activator Within 3 Hours of Acute Ischemic Stroke Current Evidence [J].
Boudreau, Denise M. ;
Guzauskas, Gregory F. ;
Chen, Er ;
Lalla, Deepa ;
Tayama, Darren ;
Fagan, Susan C. ;
Veenstra, David L. .
STROKE, 2014, 45 (10) :3032-3039
[4]   A Model of Cost-effectiveness of Tissue Plasminogen Activator in Patient Subgroups 3 to 4.5 Hours After Onset of Acute Ischemic Stroke [J].
Boudreau, Denise M. ;
Guzauskas, Greg ;
Villa, Kathleen F. ;
Fagan, Susan C. ;
Veenstra, David L. .
ANNALS OF EMERGENCY MEDICINE, 2013, 61 (01) :46-55
[5]  
Burchell SR, 2013, J INVEST MED, V61, P1078, DOI 10.2310/JIM.0b013e3182a07921
[6]   A Critical Review of Anaesthetised Animal Models and Alternatives for Military Research, Testing and Training, with a Focus on Blast Damage, Haemorrhage and Resuscitation [J].
Combes, Robert D. .
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2013, 41 (05) :385-415
[7]  
del Zoppo G, 1988, CURR CONCEPTS CEREBR, V23, P7
[8]   NXY-059 for the treatment of acute stroke - Pooled analysis of the SAINT I and II trials [J].
Diener, Hans-Christoph ;
Lees, Kennedy R. ;
Lyden, Patrick ;
Grotta, Jim ;
Davalos, Antoni ;
Davis, Stephen M. ;
Shuaib, Ashfaq ;
Ashwood, Tim ;
Wasiewski, Warren ;
Alderfer, Vivian ;
Hardemark, Hans-Goran ;
Rodichok, Larry .
STROKE, 2008, 39 (06) :1751-1758
[9]   Pathobiology of ischaemic stroke: an integrated view [J].
Dirnagl, U ;
Iadecola, C ;
Moskowitz, MA .
TRENDS IN NEUROSCIENCES, 1999, 22 (09) :391-397
[10]   Recommendations for Preclinical Research in Hemorrhagic Transformation [J].
Fagan, Susan C. ;
Lapchak, Paul A. ;
Liebeskind, David S. ;
Ishrat, Tauheed ;
Ergul, Adviye .
TRANSLATIONAL STROKE RESEARCH, 2013, 4 (03) :322-327